Literature DB >> 23699675

Medication adherence program: adherence challenges and interventions in type 2 diabetes.

Peggy Soule Odegard1, Gina Carpinito, Dale B Christensen.   

Abstract

OBJECTIVES: To describe medication adherence problems for adults with type 2 diabetes and to assess the nature and frequency of pharmacist activities in addressing them and proximate outcomes.
DESIGN: Pre-post analysis.
SETTING: Four community chain pharmacies located in Seattle, WA, from April 2008 to October 2009. PATIENTS: 120 patients (mean age >60 years) with type 2 diabetes taking oral diabetes medications and who were 6 or more days late for refills. INTERVENTION: Pharmacist telephone-initiated adherence support. MAIN OUTCOMES MEASURES: Nature and frequency of adherence-related problems and intervention activities and impact on reduction in refill gaps.
RESULTS: The primary adherence challenge was difficulty taking medications (27.1%). Failure to remember doses and forgetting refills were reported by 24.6% and 26.3% of patients at baseline, respectively. Pharmacists provided support through some form of patient education (35.6% of encounters) or other adherence support (40.7%). Pharmacist time averaged slightly greater than 5 minutes per intervention and 12.6 ± 10.7 minutes (mean ± SD) over 12 months, with 3.4 ± 2.4 interventions per patient. Patient-specific education and adherence support by pharmacists and total intervention time were positively correlated, with a modest but significant reduction in refill gaps during 12 months of follow-up.
CONCLUSION: Not remembering to refill medications was the most commonly reported problem. Patient encounters averaged 4 to 6 minutes for the first visit and 12 to 13 minutes over 12 months. Phone calls by pharmacists to adults who were late for oral diabetes medication refills were effective in identifying adherence-related problems and developing support strategies to promote medication self-management in busy urban community chain pharmacy settings.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23699675     DOI: 10.1331/JAPhA.2013.12065

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  8 in total

1.  Medication adherence in type 2 diabetes mellitus patients during Covid-19 pandemic: a cross-sectional study from the United Arab Emirates.

Authors:  Ameena Asheq; Akram Ashames; Moawia Al-Tabakha; Nageeb Hassan; Ammar Jairoun
Journal:  F1000Res       Date:  2021-06-02

2.  Whitecoat Adherence in Patients With Primary Open-Angle Glaucoma.

Authors:  Shervonne Poleon; Nouran Sabbagh; Lyne Racette
Journal:  Front Med (Lausanne)       Date:  2022-05-19

3.  Development of a new diabetes medication self-efficacy scale and its association with both reported problems in using diabetes medications and self-reported adherence.

Authors:  Betsy Sleath; Delesha M Carpenter; Susan J Blalock; Scott A Davis; Ryan P Hickson; Charles Lee; Stefanie P Ferreri; Jennifer E Scott; Lisa B Rodebaugh; Doyle M Cummings
Journal:  Patient Prefer Adherence       Date:  2016-06-07       Impact factor: 2.711

4.  Impact of a Pharmacy-Led Transition of Care Service on Post-Discharge Medication Adherence.

Authors:  Alaina Stroud; Georges Adunlin; Jessica W Skelley
Journal:  Pharmacy (Basel)       Date:  2019-08-31

Review 5.  Pharmacist-Managed Diabetes Programs: Improving Treatment Adherence and Patient Outcomes.

Authors:  Amanda Wojtusik Orabone; Vincent Do; Elizabeth Cohen
Journal:  Diabetes Metab Syndr Obes       Date:  2022-06-20       Impact factor: 3.249

6.  Nonadherence to Antihypertensive Medication Among Hypertensive Adults in the United States─HealthStyles, 2010.

Authors:  Xin Tong; Elizabeth K Chu; Jing Fang; Hilary K Wall; Carma Ayala
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-02-03       Impact factor: 3.738

7.  Group-Based Trajectory Modeling to Identify Patterns of Adherence and Its Predictors Among Older Adults on Angiotensin-Converting Enzyme Inhibitors (ACEIs)/Angiotensin Receptor Blockers (ARBs).

Authors:  Rutugandha Paranjpe; Michael L Johnson; Ekere J Essien; Jamie C Barner; Omar Serna; Esteban Gallardo; Zahra Majd; Marc L Fleming; Nancy Ordonez; Marcia M Holstad; Susan M Abughosh
Journal:  Patient Prefer Adherence       Date:  2020-10-13       Impact factor: 2.711

8.  Examining Factors Associated With Nonadherence And Identifying Providers Caring For Nonadherent Subgroups.

Authors:  Deborah A Taira; Brendan K Seto; James W Davis; Todd B Seto; Doug Landsittel; Wesley K Sumida
Journal:  J Pharm Health Serv Res       Date:  2017-08-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.